International Journal of Infectious Diseases · 2019 · 62 citations · 27 references
Veterinary MedicineInfectious DiseasesCritical Care PharmacologyNutritional Support In Critical CareSepsisBiomarkers In SepsisIntensive Care MedicineRenal DiseaseRenal Function TestsSepsis ManagementSepsis PrognosisBacteremia PrognosisC-reactive Protein TestingImpaired Kidney FunctionLeucine MetabolismMortality RatesOrgan Failure BiomarkersPhenylalanine MetabolismPlasma Albumin
OBJECTIVE: To investigate the prognostic value of phenylalanine and leucine in patients with severe infection. METHODS: Ninety-three patients with infection who had a quick Sequential Organ Failure Assessment (qSOFA) score ≥2 were enrolled. Plasma phenylalanine, leucine, albumin, C-reactive protein, pre-albumin, and transferrin were measured and the SOFA score at enrollment was calculated after hospitalization. RESULTS: During the 3-month follow-up, 30 (32.3%) patients died. Death was associated with higher SOFA scores, a higher incidence of bacteremia and admission to the intensive care unit, higher C-reactive protein and phenylalanine levels, worse kidney function, and lower pre-albumin and transferrin levels. Patients were categorized into three groups: high-risk type 1 (phenylalanine ≥84μM), high-risk type 2 (phenylalanine <84μM and leucine <93μM), and low-risk (other). Compared to the low-risk type patients, high-risk type 1 and 2 patients had higher mortality rates (hazard ratio 10.1 (95% CI 2.33-43.5) and hazard ratio 5.56 (95% CI 1.22-25.4), respectively). Type 1 patients had higher SOFA scores, a higher incidence of admission to the intensive care unit, and higher C-reactive protein and leucine levels. Type 2 patients had lower albumin and hemoglobin levels. Multivariable analysis showed that both high-risk types were independent predictors of death. CONCLUSIONS: Phenylalanine- and leucine-defined risk classifications provide metabolic information with prognostic value for patients with severe infection.
27
Assessment of Clinical Criteria for Sepsis
Christopher W. Seymour, Theodore J. Iwashyna, Frank M. Brunkhorst et al. · JAMA · 2016 · 3.8K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +17
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
Theodore J. Iwashyna, E. Wesley Ely, Dylan M. Smith et al. · JAMA · 2010 · 2.6K citations
Medicine, Neurology, Psychiatry +16
Metabolite Profiling and Cardiovascular Event Risk
Peter Würtz, Aki S. Havulinna, Pasi Soininen et al. · Circulation · 2015 · 697 citations · Full text